JAMA Internal Medicine
NOVEMBER 26, 2023
This randomized clinical trial aims to determine if a personalized, multidomain risk-reduction intervention improves cognition and dementia risk profile among adults 70 years and older.
Pharma Tutor
NOVEMBER 26, 2023
National Pharmacy Commission Bill, 2023 : A Critical Review admin Mon, 11/27/2023 - 12:22 ABOUT AUTHOR Dr. R. S. Thakur Former Secretary, Pharmacy Council of India. Email : drramsthakur@gmail.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
JAMA Internal Medicine
NOVEMBER 26, 2023
This study examines the association between years since quitting smoking and mortality in the US from 1997 to 2018.
Trialfacts
NOVEMBER 26, 2023
Contents About the Study Why Participate? Your Rights Who Can Participate? More Study Details About the Research Center: Location Research Center: Ivor Wynne Centre at McMaster University Location: Ivor Wynne Centre, Stearn Drive, Hamilton, Ontario, L8S 4E8 Lead Researcher: Tom Janssen IRB: This study has been reviewed and approved by the Hamilton Integrated Research Ethics Board (HiREB) About the Study Our bodies tend to get weaker as we age, accumulate body fat, and become less resilient to pe
JAMA Internal Medicine
NOVEMBER 26, 2023
This essay describes the author’s experience in interacting with a patient diagnosed with a serious illness and how focusing on the patient’s interests and making them happy was an example of a low-tech, high-touch intervention.
Drug Patent Watch
NOVEMBER 26, 2023
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Lithuania. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating… The post Which pharmaceutical companies have the most SPCs in Lithuania? appeared first on DrugPatentWatch - Make Better Decisions.
Expert insights. Personalized for you.
83 
Let's personalize your content